JUST IN: NAFDAC alerts public to falsified Paracetamol injection in Nigeria

NAFDAC bans registration of alcoholic drinks in sachets and glass bottles

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert over the sale of a counterfeit Paracetamol Injection, mislabeled as “Paracetamol Injection 300mg/2ml I.M I.V Aminoglycoside Antibacterial.”

The discovery was made during a surveillance action performed by the Agency’s post-marketing surveillance (PMS) section in the Federal Capital Territory of Abuja.

NAFDAC Laboratory Kaduna determined that the fraudulent medicine contained solely paracetamol, despite its labeled composition as an aminoglycoside antibacterial.

READ ALSO
Benefits Men Can Get From Sleeping Naked

Aminoglycosides are a type of antibiotics used to treat difficult bacterial infections.NAFDAC1

Did you should know?

  • The genuine Paracetamol Injection 300mg/2ml I.M I.V is manufactured by Shandong Shenglu Pharm. Co. Ltd, China, and marketed by Sifam Life Care Pharmaceutical Ltd, Kano, Nigeria.
  • It is registered by NAFDAC as an analgesic and not an Aminoglycoside Antibacterial.
  • The Certificate of Registration Holder, Sifam Life Care Pharmaceutical Ltd, has confirmed the product to be a falsified paracetamol injection.
  • NAFDAC has instructed its zonal directors and state coordinators to conduct surveillance and remove the falsified product from circulation within their respective zones and states.
READ ALSO
Consumption of `Ugwu leaves' improves fertility - Experts

Importers, distributors, retailers, healthcare professionals, and caregivers are urged to exercise caution and vigilance in the supply chain to prevent the importation, distribution, sale, and use of the falsified product.

It is emphasized that all medical products should be sourced from authorized and licensed suppliers, with careful verification of the product’s authenticity and physical condition.

READ ALSO
How Kratom Testing Services Analyze the Herb

NAFDAC encourages healthcare professionals and consumers to report any suspicions of substandard or falsified medicines or medical devices to the nearest NAFDAC office or contact NAFDAC.

Additionally, healthcare professionals and patients are urged to report any adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office or through the E-reporting platforms available on the NAFDAC.

Stay Connected , follow us on: Facebook: @creebhillsdotcom, Twitter: @creebhillsblog, Instagram: @creebhills, Pinterest: @creebhills, Telegram: @creebhills
To place an advert/Guest post on our site, contact us via [email protected]

LEAVE A REPLY

Please enter your comment!
Please enter your name here